Injectable Poly(ethylene glycol) Hydrogels Cross-Linked by Metal− Phenolic Complex and Albumin for Controlled Drug Release
Journal article
Authors/Editors
Strategic Research Themes
Publication Details
Author list: Theeraporn Bubpamala, Kwanchanok Viravaidya-Pasuwat, and Pitirat Pholpabu
Publication year: 2020
Volume number: 5
Issue number: 31
Start page: 19437
End page: 19445
Number of pages: 9
ISSN: 24701343
Languages: English-United States (EN-US)
View in Web of Science | View on publisher site | View citing articles in Web of Science
Abstract
Injectable hydrogel is advantageous as a drug reservoir for controlled drug release since its injectability provides minimally invasive access to internal tissues and irregular-shaped target sites. Herein, we fabricated pH-responsive injectable hydrogels constructed of a supramolecular cross-link network, which contained tannic acid (TA), Fe(III), poly(ethylene glycol) (PEG), and bovine serum albumin (BSA) for controlled drug release. The hydrogel precursors rapidly turned into a gel when co-injected with NaOH in a time scale of seconds. The hydrogel properties and drug release profiles are all tunable by adjusting the concentrations of BSA, NaOH, and doxorubicin (DOX). The Young’s moduli range from 3.19 ± 0.93 to 43.24 ± 1.37 kPa that match internal soft tissues. The hydrogel lasts more than 3 weeks and gradually releases doxorubicin up to 123.6 ± 1.7 μg at pH 6.4. The results of the physical properties and drug release suggest supramolecular interactions that correspond to Fourier transform infrared (FTIR) results. In vitro c totoxicit was also assessed using L929 cells, and the results demonstrated the material biocompatibility. The tunable properties, controlled release profiles, and biocompatibility of injectable poly(ethylene glycol) hydrogels support that they have great potential as a drug-releasing material for localized treatments. © 2020 American Chemical Society
Keywords
No matching items found.
Contact Information